A record of what S Prabhakar Kudva said publicly, with the source. Not advice.
Pending — not yet graded
“Bullish on Pharma for 2025, seeing it as a growth play. The sector is poised for improved fundamentals over the coming quarters, making it an attractive investment opportunity after recent market corrections.”
Nifty PharmaBullishCalled 27 Feb 2025
This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.
Read the original articleSee S Prabhakar Kudva’s full track record